Cited by 595Liver physiology and pathologyLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation

The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Open access

Zhang, Chong-Yang, Yuan, Wei-Gang, He, Pei, Lei, Jia-Hui, Wang, Chun-Xu·2016·World Journal of Gastroenterology

DOI 10.3748/wjg.v22.i48.10512PMC PMC5192262

Open this paper in CoChat — free account Open PDF

Abstract

Liver fibrosis is a reversible wound-healing process aimed at maintaining organ integrity, and presents as the critical pre-stage of liver cirrhosis, which will eventually progress to hepatocellular carcinoma in the absence of liver transplantation.Fibrosis generally results from chronic hepatic injury caused by various factors, mainly viral infection, schistosomiasis, and alcoholism; however, the exact pathological mechanisms are still unknown.Although numerous drugs have been shown to have antifibrotic activity in vitro and in animal models, none of these drugs have been shown to be efficacious in the clinic.Importantly, hepatic stellate cells (HSCs) play a key role in the initiation, progression, and regression of liver fibrosis by secreting fibrogenic factors that encourage portal fibrocytes, fibroblasts, and bone marrow-derived myofibroblasts to produce collagen and thereby propagate fibrosis.These cells are subject to intricate cross-talk with adjacent cells, resulting in scarring and subsequent liver damage.Thus, an understanding of the molecular mechanisms of liver fibrosis and their relationships with HSCs is essential for the discovery of new therapeutic targets.This comprehensive review outlines the role of HSCs in liver fibrosis and details novel strategies to suppress HSC activity, thereby providing new insights into potential treatments for liver fibrosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3748/wjg.v22.i48.10512

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Initiation, progression, and resolution of liver fibrosis involving hepatic stellate cells. Upon various types of chronic injury - including that caused by alcohol, viral and schistosome infection, nonalcoholic steatohepatitis (NASH), and other factors - hepatic stellate cells (HSCs) transdifferentiate from quiescent HSCs to activated HSCs, the latter of which secrete abundant extracellular proteins that contribute to liver fibrosis. Liver fibrosis is thought to be a reversible condition owing to the elimination of causative agents and different strategies of limiting HSC activation; however, they cannot totally return to a quiescent status of the naive HSCs. Instead, they exhibit a pre-activated intermediate condition with an increased sensitivity to injury. Thus, preventing recurrent chronic liver injury is of great importance in patients undergoing treatment for liver fibrosis. Untreated or relapsed fibrosis progresses to liver cirrhosis, which often requires hepatic transplantation.CC BY-NC · PubMed Central

Figure 2 Roles of interleukin-30, hydrogen peroxide inducible clone 5, and cholesterol acyltransferase 1 in liver fibrosis.CC BY-NC · PubMed Central

Figure 3 Roles of the Wnt, TGF-β/Smad, and Gas6/Axl signaling pathways in the progression of liver fibrosis.CC BY-NC · PubMed Central

Figure 4 Mechanism of action of three potential therapeutic drugs-ursolic acid, 24-nor-ursodeoxycholic acid, and resveratrol-for treating fibrosis.CC BY-NC · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
Vernon, G. C., Baranova, A. V., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,116
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck‐Radosavljevic, M., Valla, D. C., & Roudot‐Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,340
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 913
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway
Feldstein, A. E., Werneburg, N. W., Canbay, A. E., Guicciardi, M. E., Bronk, S. F., Rydzewski, R. M., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 851
CYP2E1 and oxidative liver injury by alcohol
Lu, Y., & Cederbaum, A. I. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.11.004 · Cited by 805
Hepatic fibrosis: concept to treatment
Trautwein, C., Friedman, S. L., Schuppan, D., & Pinzani, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.039 · Cited by 677
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol
Um, J.-H., Park, S.-J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, M. K., Viollet, B., & Chung, J. H. (2010) · Diabetes · doi:10.2337/db09-0482 · Cited by 647
Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613
Non-alcoholic fatty liver disease: The mist gradually clears
de Alwis, N. M. W., & Day, C. P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.009 · Cited by 605
Immunopathology of schistosomiasis
Wilson, M. S., Mentink‐Kane, M. M., Pesce, J. T., Ramalingam, T. R., Thompson, R. W., & Wynn, T. A. (2006) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100014 · Cited by 474
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update
Elpek, G. Ö. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7260 · Cited by 399
Anti-Inflammatory Responses of Resveratrol
Das, S., & Das, D. K. (2007) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152807781696464 · Cited by 383
Experimental models of liver fibrosis
Yanguas, S. C., Cogliati, B., Willebrords, J., Maes, M., Colle, I. O., Bossche, B. V. D., de Oliveira, C. P. M. S., Andraus, W., Alves, V. A. F., Leclercq, I. A., et al. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1543-4 · Cited by 364
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
Sitia, G., Aiolfi, R., Lucia, P. D., Mainetti, M., Fiocchi, A., Mingozzi, F., Esposito, A., Ruggeri, Z., Chisari, F., Iannacone, M., et al. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1209182109 · Cited by 318
Resveratrol alleviates alcoholic fatty liver in mice
Ajmo, J. M., Liang, X., Rogers, C. Q., Pennock, B., & You, M. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90358.2008 · Cited by 314
Recent advancement of molecular mechanisms of liver fibrosis
Seki, E., & Brenner, D. A. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.245 · Cited by 302
The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families
Murakami, Y., Toyoda, H., Tanaka, M., Kuroda, M., Harada, Y., Matsuda, F., Tajima, A., Kosaka, N., Ochiya, T., & Shimotohno, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016081 · Cited by 283
miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis
Guo, C., Pan, Q., Li, D., Sun, H., & Liu, B. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.11.025 · Cited by 280
Reversibility of liver fibrosis
Sun, M., & Kisseleva, T. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.06.015 · Cited by 280
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
Ehling, J., Bartneck, M., Wei, X., Gremse, F., Fech, V., Möckel, D., Baeck, C., Hittatiya, K., Eulberg, D., Luedde, T., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306294 · Cited by 273
Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes
Popov, Y. V., Patsenker, E., Fickert, P., Trauner, M. A., & Schuppan, D. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.025 · Cited by 268
Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high‐fat diet
Ito, M., Suzuki, J., Tsujioka, S., Sasaki, M., Gomori, A., Shirakura, T., Hirose, H., Ito, M., Ishihara, A., Iwaasa, H., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00008.x · Cited by 263
Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes
Moshage, H. J., Casini, A., & LIEBER, C. S. (1990) · Hepatology · doi:10.1002/hep.1840120311 · Cited by 251
Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver
Gustot, T., Lemmers, A., Moreno, C., Nagy, N., Quertinmont, E., Nicaise, C., Franchimont, D. P., Louis, H., Deviere, J. M., & Moine, O. L. (2006) · Hepatology · doi:10.1002/hep.21138 · Cited by 249
Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution
Baiocchini, A., Montaldo, C., Conigliaro, A., Grimaldi, A., Correani, V., Mura, F., Ciccosanti, F., Rotiroti, N., Brenna, A., Montalbano, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151736 · Cited by 244
SIRT1 Controls the Transcription of the Peroxisome Proliferator-activated Receptor-γ Co-activator-1α (PGC-1α) Gene in Skeletal Muscle through the PGC-1α Autoregulatory Loop and Interaction with MyoD
Amat, R., Planavila, A., Chen, S. L., Iglesias, R., Giralt, M., & Villarroya, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022749 · Cited by 224
Transforming growth factor β1 induces the expression of α1(i) procollagen mRNA by a hydrogen peroxide‐C/EBPβ‐dependent mechanism in rat hepatic stellate cells
García-Trevijano, E., Iraburu, M., Fontana, L., Domínguez-Rosales, J., Auster, A., Covarrubias‐Pinedo, A., & Rojkind, M. (1999) · Hepatology · doi:10.1002/hep.510290346 · Cited by 223
Standard Operating Procedures in Experimental Liver Research: Thioacetamide model in mice and rats
Wallace, M., Hamesch, K., Lunová, M., Kim, Y., Weiskirchen, R., Strnad, P., & Friedman, S. (2015) · Laboratory Animals · doi:10.1177/0023677215573040 · Cited by 211
Mechanisms of liver fibrosis resolution
Tacke, F., & Trautwein, C. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.039 · Cited by 207
Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology
Chuah, C., Jones, M. K., Burke, M. L., McManus, D. P., & Gobert, G. N. (2014) · Trends in Parasitology · doi:10.1016/j.pt.2013.12.009 · Cited by 202
MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases
He, Y., Huang, C. Z., Lin, X., & Li, J. (2013) · Biochimie · doi:10.1016/j.biochi.2013.03.010 · Cited by 197
Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats
Schmatz, R., Pereira, L. B., Stefanello, N., Mazzanti, C. M. D. A., Spanevello, R. M., Gutierres, J. M., Bagatini, M. D., Martins, C. C., Abdalla, F. H., Serres, J. D. D. S., et al. (2011) · Biochimie · doi:10.1016/j.biochi.2011.08.005 · Cited by 192
Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism
Casini, A., Cunningham, M., Rojkind, M., & Lieber, C. S. (1991) · Hepatology · doi:10.1002/hep.1840130424 · Cited by 190
Hydrogen peroxide: A link between acetaldehyde-elicited α1(i) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells
Greenwel, P., Domı́nguez-Rosales, J. A., Mavi, G., Rivas-Estilla, A. M., & Rojkind, M. (2000) · Hepatology · doi:10.1002/hep.510310118 · Cited by 189
Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet
Ahn, J., Cho, I., Kim, S., Kwon, D., & Ha, T. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.012 · Cited by 173
Pathophysiology of Liver Fibrosis
Pinzani, M. (2015) · Digestive Diseases · doi:10.1159/000374096 · Cited by 164
Liver Fibrosis: From Pathogenesis to Novel Therapies
Weiskirchen, R., & Tacke, F. (2016) · Digestive Diseases · doi:10.1159/000444556 · Cited by 162
Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation
Bárcena, C., Stefanović, M., Tutusaus, A., Joannas, L. D., Menéndez, A., García‐Ruiz, C., Sancho‐Bru, P., Marı́, M., Caballería, J., Rothlin, C. V., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.013 · Cited by 154
Wnt signaling in liver fibrosis: Progress, challenges and potential directions
Miao, C., Yang, Y., He, X., Huang, C. Z., Huang, Y., Zhang, L., Lv, X., Jin, Y. J., & Li, J. (2013) · Biochimie · doi:10.1016/j.biochi.2013.09.003 · Cited by 148
Inflammation and fibrogenesis in steatohepatitis
Fujii, H., & Kawada, N. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0527-x · Cited by 140
Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats
Pascoli, M. D., Diví, M., Rodrı́guez-Vilarrupla, A., Rosado, E., Gracia‐Sancho, J., Vilaseca, M., Bosch, J., & García‐Pagán, J. C. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.012 · Cited by 136
Intracellular Signaling Pathways Involved in Acetaldehyde–Induced Collagen and Fibronectin Gene Expression in Human Hepatic Stellate Cells
Svegliati‐Baroni, G., Ridolfi, F., Sario, A. D., Saccomanno, S., Bendia, E., Benedetti, A., & Greenwel, P. (2001) · Hepatology · doi:10.1053/jhep.2001.23788 · Cited by 134
miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis
Roderburg, C., Luedde, M., Cardenas, D. V., Vucur, M., Mollnow, T., Zimmermann, H. W., Koch, A. H., Hellerbrand, C., Weiskirchen, R., Frey, N., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.022 · Cited by 130
Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice
Cho, S.-J., Jung, U. J., & Choi, M. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000347 · Cited by 130
Liver fibrosis: Common mechanisms and antifibrotic therapies
Schuppan, D. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.05.005 · Cited by 126
Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
Kitano, M., & Bloomston, M. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5030038 · Cited by 124
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice
Arsov, T., Larter, C. Z., Nolan, C. J., Petrovsky, N., Goodnow, C. C., Teoh, N., Yeh, M. M., & Farrell, G. C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.032 · Cited by 118
The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model
Butura, A., Nilsson, K. C., Morgan, K., Morgan, T. R. M., French, S. W., Johansson, I., Schuppe‐Koistinen, I., & Ingelman‐Sundberg, M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.020 · Cited by 113
Role of adipose tissue in methionine–choline-deficient model of non-alcoholic steatohepatitis (NASH)
Jha, P., Knopf, A., Köfeler, H. C., Mueller, M., Lackner, C., Höefler, G., Claudel, T., & Trauner, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.02.012 · Cited by 99
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis
Morales‐Ibanez, O., Domínguez, M., Ki, S. H., Marcos, M., Chaves, F. J., Nguyen-Khac, É., Houchi, H., Affò, S., Sancho‐Bru, P., Altamirano, J., et al. (2013) · Hepatology · doi:10.1002/hep.26521 · Cited by 97
Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells
Tomita, K., Teratani, T., Suzuki, T., Shimizu, M., Sato, H., Narimatsu, K., Usui∥, S., Furuhashi, H., Kimura, A., Nishiyama, K., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.018 · Cited by 96
IL-30 (IL27p28) Attenuates Liver Fibrosis Through Inducing NKG2D-Rae1 Interaction Between NKT and Activated Hepatic Stellate Cells in Mice
Mitra, A., Satelli, A., Yan, J., Xueqing, X., Gagea, M., Hunter, C. A., Mishra, L., & Li, S. (2014) · Hepatology · doi:10.1002/hep.27392 · Cited by 94
Development of Hepatocellular Adenomas and Carcinomas Associated with Fibrosis in C57BL/6J Male Mice Given a Choline‐deficient, L‐Amino Acid‐defined Diet
Denda, A., Kitayama, W., Kishida, H., Murata, N., Tsutsumi, M., Tsujiuchi, T., Nakae, D., & Konishi, Y. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01250.x · Cited by 93
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
The Osteopontin Level in Liver, Adipose Tissue and Serum Is Correlated with Fibrosis in Patients with Alcoholic Liver Disease
Patouraux, S., Bonnafous, S., Voican, C. S., Anty, R., Saint‐Paul, M., Rosenthal‐Allieri, M. A., Agostini, H., Njiké‐Nakseu, M., Barri‐Ova, N., Naveau, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035612 · Cited by 88
Osteopontin: Versatile modulator of liver diseases
Nagoshi, S. (2013) · Hepatology Research · doi:10.1111/hepr.12166 · Cited by 87
Early response of α2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF‐β independent†
Svegliati‐Baroni, G., Inagaki, Y., Rincón‐Sánchez, A. R., Else, C., Saccomanno, S., Benedetti, A., Ramirez, F., & Rojkind, M. (2005) · Hepatology · doi:10.1002/hep.20798 · Cited by 87
Liver Fibrosis: Causes and Methods of Assessment, A Review
Erfani, A. (2015) · Romanian Journal of Internal Medicine · doi:10.1515/rjim-2015-0039 · Cited by 83
Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells
Wang, X., Ikejima, K., Kon, K., Arai, K., Aoyama, T., Okumura, K., Abe, W., Sato, N., & Watanabe, S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.040 · Cited by 82
Schistosomiasis Prevalence and Intensity of Infection in Latin America and the Caribbean Countries, 1942-2014: A Systematic Review in the Context of a Regional Elimination Goal
Zoni, A. C., Català, L., & Ault, S. K. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004493 · Cited by 79
MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis
Yu, F., Lu, Z., Huang, K., Wang, X., Xu, Z., Chen, B., Dong, P., & Zheng, J. (2015) · Oncotarget · doi:10.18632/oncotarget.6447 · Cited by 78
Impaired CD4+ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients
Glässner, A., Eisenhardt, M., Kokordelis, P., Krämer, B., Wolter, F., Nischalke, H. D., Boesecke, C., Sauerbruch, T., Rockstroh, J. K., Spengler, U., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.029 · Cited by 75
Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging
Li, D., He, L., Guo, H., Chen, H., & Shan, H. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0151-x · Cited by 74
Bariatric Surgery-Induced Weight Loss Reduces Hepatic Lipid Peroxidation Levels and Affects Hepatic Cytochrome P-450 Protein Content
Bell, L. N., Temm, C. J., Saxena, R., Vuppalanchi, R., Schauer, P. R., Rabinovitz, M., Krasinskas, A. M., Chalasani, N., & Mattar, S. G. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181dbb572 · Cited by 72
miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan
Halász, T. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7814 · Cited by 69
Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway
Lee, J., Jang, E. J., Seo, H. L., Ku, S., Lee, J. R., Shin, S. S., Park, S., Kim, S. C., & Kim, Y. W. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.10.005 · Cited by 69
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis
Sombetzki, M., Fuchs, C. D., Fickert, P., Österreicher, C. H., Mueller, M., Claudel, T., Loebermann, M., Engelmann, R., Langner, C., Sahin, E., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.020 · Cited by 69
Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice
Lei, X., Fu, W., Kim‐Kaneyama, J., Omoto, T., Miyazaki, T., Li, B., & Miyazaki, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.026 · Cited by 69
Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
Nagao, Y., Kawahigashi, Y., & Sata, M. (2014) · Hepatitis Monthly · doi:10.5812/hepatmon.23264 · Cited by 64
Assessing inflammatory liver injury in an acute CCl4 model using dynamic 3D metabolic imaging of hyperpolarized [1‐13C]pyruvate
Josan, S., Billingsley, K. L., Orduna, J. M., Park, J. M., Luong, R. H., Yu, L., Hurd, R. E., Pfefferbaum, A., Spielman, D. M., & Mayer, D. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3431 · Cited by 63
Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma
van Dijk, F., Olinga, P., Poelstra, K., & Beljaars, L. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00072 · Cited by 60
A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells
Park, K. C., Park, J. H., Jeon, J. Y., Kim, S. Y., Kim, J. M., Lim, C. Y., Lee, T. H., Kim, H. K., Lee, H. G., Kim, S. M., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12590 · Cited by 57
Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts
Lepreux, S., & Desmoulière, A. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00173 · Cited by 57
Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy
Schmid, P., Bregenzer, A., Huber, M., Rauch, A., Jochum, W., Müllhaupt, B., Vernazza, P., Opravil, M., Weber, R. K., & Study, S. H. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138838 · Cited by 56
Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis
Barnes, M. A., McMullen, M. R., Roychowdhury, S., Madhun, N. Z., Niese, K. A., Olman, M. A., Stavitsky, A. B., Bucala, R., & Nagy, L. E. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0614-280r · Cited by 54
The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis
Yan, C., Wang, L., Li, B., Zhang, B., Zhang, B., Wang, Y., Li, X., Chen, J., Tang, R., & Zheng, K. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0675-y · Cited by 53
SMAD7: a timer of tumor progression targeting TGF-β signaling
Luo, L., Li, N., Lv, N., & Huang, D. (2014) · Tumor Biology · doi:10.1007/s13277-014-2203-7 · Cited by 52
Cell therapy in chronic liver disease
Nicolas, C. T., Wang, Y., & Nyberg, S. L. (2016) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000262 · Cited by 50
HAb18G/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis
Zhang, D.-W., Zhao, Y.-X., Wei, D., Li, Y., Zhang, Y., Wu, J., Xu, J., Chen, C., Tang, H., Zhang, W., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.042 · Cited by 49
Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica
Zhang, Y., Huang, D., Gao, W., Yan, J., Zhou, W., Hou, X., Liu, M., Ren, C., Wang, S., & Shen, J. (2015) · International Immunology · doi:10.1093/intimm/dxv017 · Cited by 49
Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
Zhang, C., Yuan, W., Fang, J., Wang, W., He, P., Lei, J., & Wang, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161792 · Cited by 47
Self-citation
Carbogen Gas–Challenge BOLD MR Imaging in a Rat Model of Diethylnitrosamine-induced Liver Fibrosis
Jin, N., Deng, J., Chadashvili, T., Zhang, Y., Guo, Y., Zhang, Z., Yang, G., Omary, R. A., & Larson, A. C. (2009) · Radiology · doi:10.1148/radiol.09090410 · Cited by 47
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection
Sacchi, P., Cima, S., Corbella, M., Comolli, G., Chiesa, A., Baldanti, F., Klersy, C., Novati, S., Mulatto, P., Mariconti, M., et al. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.11.012 · Cited by 44
microRNA-222 modulates liver fibrosis in a murine model of biliary atresia
Shen, W.-J., Dong, R., Chen, G., & Zheng, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.065 · Cited by 42
Endothelial Nrf2 activation: a new target for resveratrol?
Haskó, G., & Pacher, P. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00436.2010 · Cited by 42
Mest Attenuates CCl4-Induced Liver Fibrosis in Rats by Inhibiting the Wnt/β-Catenin Signaling Pathway
Li, W., Zhu, C., Li, Y., Wu, Q., & Gao, R. (2014) · Gut and Liver · doi:10.5009/gnl.2014.8.3.282 · Cited by 38
Parenchymal transforming growth factor beta‐1: Its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology
Calabrese, F., Valente, M., Giacometti, C., Pettenazzo, E., Benvegnù, L., Alberti, A., Gatta, A., & Pontisso, P. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03162.x · Cited by 35
Effects of acetaldehyde on nuclear protein binding to the nuclear factor I consensus sequence in the α2(I) collagen promoter
Anania, F. A., Potter, J. J., Rennie-Tankersley, L., & Mezey, E. (1995) · Hepatology · doi:10.1002/hep.1840210624 · Cited by 33
Crucial steps towards an effective treatment
Poelstra, K. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.224 · Cited by 33
Human urokinase-type plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by down-regulating the Wnt signaling pathway
Ma, Z. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i6.2092 · Cited by 33
The functional size of acyl-coenzyme A (CoA):cholesterol acyltransferase and acyl-CoA hydrolase as determined by radiation inactivation.
Billheimer, J. T., Cromley, D. A., & Kempner, E. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38934-3 · Cited by 33
Reversion of hepatic stellate cell to a quiescent phenotype: From myth to reality?
Mallat, A., & Lotersztajn, S. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.031 · Cited by 30
CCAAT/Enhancer Binding Protein β Mediates the Activation of the Murine α1(I) Collagen Promoter by Acetaldehyde
Attard, F. A., Wang, L., Potter, J. J., Rennie-Tankersley, L., & Mezey, E. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1803 · Cited by 30
TGF-β induced miR-132 enhances the activation of TGF-β signaling through inhibiting SMAD7 expression in glioma cells
Wang, Z., Zhang, Q., Duan, Y.-L., Zhang, J.-L., Li, G.-F., & Zheng, D.-L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.001 · Cited by 29
Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression
Wu, J., Hu, C., You, R.-I., Pan, S.-M., Cheng, C.-C., Lee, M., Wu, C., Chang, Y.-J., Lin, S., Chen, C.-S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5322 · Cited by 27
Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis.
Qu, Y., Zong, L., Xu, M., Dong, Y., & Lu, L. (2015) · Europe PMC (PubMed Central) · Cited by 24
Hydrogen Peroxide-Inducible Clone 5 (Hic-5) as a Potential Therapeutic Target for Vascular and Other Disorders
Kim‐Kaneyama, J., Lei, X., Arita, S., Miyauchi, A., Miyazaki, T., & Miyazaki, A. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10736 · Cited by 22
Carbon tetrachloride-induced lipid peroxidation and hyperglycemia in rat
Khan, R. A., Khan, M. R., Sahreen, S., Ahmed, M., & Shah, N. A. (2013) · Toxicology and Industrial Health · doi:10.1177/0748233713475503 · Cited by 21
Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians
Lin, H., Ha, N. B., Ahmed, A., Ayoub, W. S., Daugherty, T. J., Lutchman, G. A., García, G., & Nguyen, M. H. (2013) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-013-9871-z · Cited by 18
Effects and Mechanisms ofAcremoniumterricola milleretal myceliumon Liver Fibrosis Induced by Carbon Tetrachloride in Rats
Tian, X., Yin, Y., & Li, X. (2011) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x11009019 · Cited by 18
Anti-fibrotic Effects of a Methylenedioxybenzene Compound, CW209292 on Dimethylnitrosamine-Induced Hepatic Fibrosis in Rats
Oh, S., Kim, D., Ha, J.-R., & Kim, D.-Y. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1364 · Cited by 17
Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
Rao, H., Wei, L., Li, J., Zhang, L., Chen, H., Zhu, L.-M., Liu, F., Sun, Y., & Wang, H. (2009) · PubMed · Cited by 12
Failure of Repeated Treatment With Praziquantel and Arthemeter in Four Patients With Acute Schistosomiasis
Praticò, L., Mariani, B., Brunetti, E., Maserati, R., Bruno, A., Novati, S., & Chichino, G. (2014) · Journal of Travel Medicine · doi:10.1111/jtm.12098 · Cited by 10
Schistosomiasis associated with a mediastinal mass: case report and review of the literature
Al‐Fawaz, I. M., Al-Rasheed, S. A., Al-Majed, S. A., & Ashour, M. (1990) · Annals of Tropical Paediatrics · doi:10.1080/02724936.1990.11747445 · Cited by 9
IMMUNOPATHOLOGY OF SCHISTOSOMIASIS
(1987) · The Lancet · doi:10.1016/s0140-6736(87)90771-9 · Cited by 7
IMMUNITY TO SCHISTOSOMIASIS
Smithers, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92278-1 · Cited by 5
Gas6/Axl in arginine-starvation therapy
Tsai, W.-B., long, Y. N., & Kuo, M. T. (2015) · Oncoscience · doi:10.18632/oncoscience.218 · Cited by 4
ERRATUM for the paper Erfani A. Liver Fibrosis: Causes and Methods of Assessment, A Review. Rom J Intern Med. 2015; 53(4):304-14
Erfani, A. (2017) · Romanian Journal of Internal Medicine · doi:10.1515/rjim-2017-0052 · Cited by 2
Tregs: A Therapeutic Target for the Treatment of Portal Fibrosis?
Xue, Y., & Michalopoulos, G. K. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3687-8 · Cited by 2

Research works printed but not linked: 1

10.1002/cphy.c120035 · DOI · Paper page

Sorted by citations

Wound healing, fibroblast heterogeneity, and fibrosis
desJardins-Park, H. E., Mascharak, S., Griffin, M., Wan, D. C., & Longaker, M. T. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.07.006 · Cited by 835
Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs
Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 744
Liver fibrosis
Aydin, M. M., & Akçalı, K. C. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.17330 · Cited by 397
The double edge sword of fibrosis in cancer
Chandler, C., Liu, T., Buckanovich, R. J., & Coffman, L. G. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.006 · Cited by 257
RETRACTED ARTICLE: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
Moghadasi, S., Elveny, M., Rahman, H. S., Suksatan, W., Jalil, A. T., Abdelbasset, W. K., Yumashev, A. V., Shariatzadeh, S., Motavalli, R., Behzad, F., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02980-6 · Cited by 207
Retracted

See all 595

Authors: Zhang, C.-Y., Yuan, W.-G., He, P., Lei, J.-H., & Wang, C.-X.
Affiliations: Huazhong University of Science and Technology (CN)
Venue: World Journal of Gastroenterology
Publisher: Baishideng Publishing Group Inc.
Published: 2016
Volume: 22
Issue: 48
Pages: 10512
ISSN: 1007-9327 (ISSN-L)
DOI: 10.3748/wjg.v22.i48.10512
PMC: PMC5192262
OpenAlex: W2565367159
Cited by: 594
References: 112
Citations by year: 2026: 37 · 2025: 70 · 2024: 75 · 2023: 80 · 2022: 84 · 2021: 88 · 2020: 60 · 2019: 59 · 2018: 24 · 2017: 15
FWCI: 4.07
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: World Journal of Gastroenterology (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (81300251)
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords: liver fibrosis, hepatic stellate cells, liver cirrhosis, hepatocellular carcinoma, antifibrotic therapy, fibrogenic factors, collagen synthesis, myofibroblasts, viral hepatitis, schistosomiasis, alcoholic liver disease, cell-cell crosstalk, therapeutic target
MeSH terms: Resveratrol, Ursolic Acid, Acetyl-CoA C-Acetyltransferase, Animals, Fatty Liver, Alcoholic, Humans, Interleukins, Liver Cirrhosis, Macrophages, Schistosomiasis, Stilbenes, Triterpenes, Ursodeoxycholic Acid, Virus Diseases, Signal Transduction, CD4-Positive T-Lymphocytes, Disease Progression, MicroRNAs, Intracellular Signaling Peptides and Proteins, T-Lymphocytes, Regulatory, Hepatic Stellate Cells, Molecular Targeted Therapy, LIM Domain Proteins, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks